טוען...
GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
Diabetes mellitus is a chronic disease prevalence of which is high and continually growing. Cardiovascular disease continues to be the leading cause of death in patients with T2DM. The prevention of cardiovascular complications and the cardiovascular safety of treatments should be a primary objectiv...
שמור ב:
| הוצא לאור ב: | J Diabetes Res |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5902002/ https://ncbi.nlm.nih.gov/pubmed/29805980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4020492 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|